Tag Archives: pipeline

Pipeline Report Preview

Posted in Advertising, Biotech, Europe, FDA, Gene therapy, Global, IP, R&D, Regulatory, Strategy, Video | Also tagged , , , , , , , , | Leave a comment

Public Interest in Private Science: New Pathways to Measuring R&D Success

Today’s big product story — the apparent end to a decade-long drought in the drug development pipeline — is the prep stage for tomorrow’s big policy question:  are industry R&D priorities in synch with the changing burden of disease?
Posted in FDA, R&D | Also tagged , , | Leave a comment

Witty Touts GSK Pipeline in 4th Quarter Review

Posted in Emerging Markets, Europe, Global, News, R&D, Strategy | Also tagged , , , , , | Leave a comment

How Do We Raise R&D Productivity?

That’s the big question that no one has answered yet. So perhaps its worth breaking it down into smaller parts, suggests Dr Brian D Smith. An ill-posed question is a mathematician’s term that well describes what many Big Pharma companies are asking themselves, namely, how can we raise R&D productivity? It’s ill-posed because it has […]
Posted in Europe, Global, Guest Blog, Marketing, Strategy | Also tagged , , | Leave a comment

Astellas and OSI Come Together

The months-long saga is finally over: Astellas’ enhanced offer of $57.50 a share—around $4 billion—has finally netted it Melville, NY-based OSI Pharmaceuticals. The Japan-based pharma first extended an acquisition offer of $52 per share ($3.5 billion) to OSI on March 1, only to be met with a resounding “Nay” from the board, which said $52 […]
Posted in Deals, News, Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta